June 30, 2026 · Form 4 insider transaction
Lorrain Daniel S. sold 28,826 shares of Contineum Therapeutics, Inc. at $16.04 per share, a transaction worth $462.3K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
These transactions were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 23, 2025.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.00 to $16.35, inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.